TEVA
Teva Pharma Industries Ltd ADR
Teva Pharma Industries Ltd ADR historical holders
total: 10
Sound Shore Management Teva Pharma Industries Ltd ADR transactions over time
- Total transactions:
- 11
- New positions:
- 1
- Added:
- 3
- Reduced:
- 7
- Held since:
- 2023 Q3
- Held for:
- 11 quarters
- Latest activity:
- 2026 Q1
Harry Burn has been an institutional investor in Teva Pharma Industries Ltd ADR (TEVA) since 2023 Q3. According to 2026 Q1 report, Harry Burn holds 3,885,683 shares with a market value of roughly $117.04M representing 3.92% of their equity portfolio. The fund/company first acquired TEVA in 2023 Q3, initially purchasing about 7.92M shares. Since the initial investment, Sound Shore Management has made 10 more transactions in this position.
Does Harry Burn still hold TEVA?
Yes, Harry Burn continues to hold Teva Pharma Industries Ltd ADR (TEVA). According to their 2026 Q1 report, they maintain a position of 3,885,683 shares valued at approximately $117.04M, representing 3.92% of their equity portfolio.
When did Harry Burn first invest in TEVA?
Harry Burn first invested in Teva Pharma Industries Ltd ADR (TEVA) in 2023 Q3 at the reported quarter-end price of $10.20 per share, acquiring 7,920,712 shares in their initial purchase.
What is Harry Burn's average cost basis for TEVA?
Based on historical transaction data, Harry Burn's estimated cost basis for Teva Pharma Industries Ltd ADR (TEVA) is approximately $10.83 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $10.83
- Weighted AVG sell price:
- $21.49
TEVA transactions history by Sound Shore Management
11 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
3.92%
|
3,885,683
|
$30.12
|
$117,036,772
|
-9.84% (-424,223)
|
-0.41%
|
|
2025 Q4
|
4.28%
|
4,309,906
|
$31.21
|
$134,512,166
|
-23.68% (-1,337,543)
|
-1.38%
|
|
2025 Q3
|
3.77%
|
5,647,449
|
$20.20
|
$114,078,470
|
-3.40% (-199,063)
|
-0.14%
|
|
2025 Q2
|
3.34%
|
5,846,512
|
$16.76
|
$97,987,541
|
+7.23% (+394,423)
|
+0.23%
|
|
2025 Q1
|
2.94%
|
5,452,089
|
$15.37
|
$83,798,608
|
+14.23% (+679,377)
|
+0.37%
|
|
2024 Q4
|
3.47%
|
4,772,712
|
$22.04
|
$105,190,573
|
-20.15% (-1,204,132)
|
-0.86%
|
|
2024 Q3
|
3.50%
|
5,976,844
|
$18.02
|
$107,702,728
|
-11.60% (-784,602)
|
-0.47%
|
|
2024 Q2
|
3.66%
|
6,761,446
|
$16.25
|
$109,873,498
|
-9.78% (-733,244)
|
-0.37%
|
|
2024 Q1
|
3.31%
|
7,494,690
|
$14.11
|
$105,750,076
|
-15.97% (-1,424,544)
|
-0.7%
|
|
2023 Q4
|
3.23%
|
8,919,234
|
$10.44
|
$93,116,803
|
+12.61% (+998,522)
|
+0.36%
|
|
2023 Q3
|
3.09%
|
$10.20
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.